Search Results

[Treatment of hepatitis C infection: towards eradication of chronic virus].

• Authors : Ahola T; Helsingin yliopisto, Biotekniikan instituutti.; Kaukinen P

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2012; Vol. 128 (18), pp. 1911-7.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].

• Authors : Remes K; TYKS:n sisätautien klinikka, Turku, Finland.; Pelliniemi TT

Subjects: Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use ; Thrombocytosis/Thrombocytosis/Thrombocytosis/*therapy; Adult

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 1993; Vol. 109 (11), pp. 983-9.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Interferon is useful in the treatment of chronic hepatitis B].

• Authors : Vuoristo M

Subjects: Hepatitis B/Hepatitis B/Hepatitis B/*drug therapy ; Hepatitis, Chronic/Hepatitis, Chronic/Hepatitis, Chronic/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 1991; Vol. 107 (13), pp. 1087-90.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Diagnostics and drug therapy of multiple sclerosis].

• Authors : Suomen Neurologinen Yhdistys ry

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Interferon-beta/Interferon-beta/Interferon-beta/*therapeutic use

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2002; Vol. 118 (13), pp. 1411-23.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[MS patients should get beta-interferon therapy early and for a long time].

• Authors : Ruutiainen J

Subjects: Interferon-beta/Interferon-beta/Interferon-beta/*therapeutic use ; Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/Multiple Sclerosis, Relapsing-Remitting/*drug therapy; Health Services Accessibility

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2001; Vol. 117 (17), pp. 1693-5.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Drug therapy of multiple sclerosis].

• Authors : Kinnunen E; Hyvinkään aluesairaala, neurologian yksikko Sairaalankatu 1 05850 Hyvinkää.

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use ; Immunoglobulins/Immunoglobulins/Immunoglobulins/*therapeutic use ; Interferon-beta/Interferon-beta/Interferon-beta/*therapeutic use

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 1999; Vol. 115 (4), pp. 403-7.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Beta interferon and multiple sclerosis].

• Authors : Kinnunen E; Department of Neurology, Jyvaskyla Central Hospital, Finland.

Subjects: Interferon-beta/Interferon-beta/Interferon-beta/*administration & dosage ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*drug therapy; Adolescent

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 1996; Vol. 112 (24), pp. 2368-73.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Interferon-beta in the treatment of multiple sclerosis].

• Authors : Panelius M; Salonen R; Ruutiainen J

Subjects: Interferon-beta/Interferon-beta/Interferon-beta/*therapeutic use ; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*therapy; Drug Costs

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 1995; Vol. 111 (7), pp. 587-9.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Update on current care guidelines: melanoma].

Subjects: Melanoma/Melanoma/Melanoma/*diagnosis ; Melanoma/Melanoma/Melanoma/*therapy ; Skin Neoplasms/Skin Neoplasms/Skin Neoplasms/*diagnosis

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2012; Vol. 128 (9), pp. 988-9.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details

[Drug therapy of hepatitis B and C].

• Authors : Färkkilä M; HYKS, sisätaudit, gastroenterologian klinikka PL 340, 00029 HUS.

Subjects: Hepatitis B/Hepatitis B/Hepatitis B/*drug therapy ; Hepatitis C/Hepatitis C/Hepatitis C/*drug therapy; Antiviral Agents/Antiviral Agents/Antiviral Agents/therapeutic use

• Source: Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2003; Vol. 119 (6), pp. 519-29.Publisher: Laaeketieteellinen Aikakauskirja Duodecim Country of Publication: Finland NLM ID: 0373207 Publication Model: Print Cited Medium: Print

Record details